Efficacy News and Research

RSS
Study determines the mechanism behind respiratory inflammation and finds effective treatment

Study determines the mechanism behind respiratory inflammation and finds effective treatment

Do the Moderna and Pfizer COVID-19 vaccines elicit different antibody responses?

Do the Moderna and Pfizer COVID-19 vaccines elicit different antibody responses?

What is the optimal dosing regimen for remdesivir in COVID-19 patients? A computational model

What is the optimal dosing regimen for remdesivir in COVID-19 patients? A computational model

Is liquid chalk an effective disinfectant of SARS-CoV-2 and influenza viruses?

Is liquid chalk an effective disinfectant of SARS-CoV-2 and influenza viruses?

Researchers screen Chinese herbal medicines and plant compounds for anti-SARS-CoV-2 activity

Researchers screen Chinese herbal medicines and plant compounds for anti-SARS-CoV-2 activity

LegoChem Biosciences and Iksuda Therapeutics expand License Agreement for development of antibody-drug conjugates

LegoChem Biosciences and Iksuda Therapeutics expand License Agreement for development of antibody-drug conjugates

Study: Immune responses may develop against other proteins produced by SARS-CoV-2

Study: Immune responses may develop against other proteins produced by SARS-CoV-2

RedHill presents positive Phase 2 results for oral opaganib in patients with COVID-19 pneumonia

RedHill presents positive Phase 2 results for oral opaganib in patients with COVID-19 pneumonia

FLASH radiotherapy could revolutionize future tumor treatments

FLASH radiotherapy could revolutionize future tumor treatments

Dual-antibody combination therapies effective against SARS-CoV-2 variants in animal study

Dual-antibody combination therapies effective against SARS-CoV-2 variants in animal study

FDA approves oral pellets to treat children with venous thromboembolism

FDA approves oral pellets to treat children with venous thromboembolism

Study reviews natural drug candidates for potential treatment of COVID-19

Study reviews natural drug candidates for potential treatment of COVID-19

Researchers identify four substances that inhibit SARS-CoV-2 replication in cells

Researchers identify four substances that inhibit SARS-CoV-2 replication in cells

Can a prior rhinovirus infection protect against COVID-19?

Can a prior rhinovirus infection protect against COVID-19?

Can convalescent plasma therapy improve COVID-19 outcomes in patients with hematologic cancers?

Can convalescent plasma therapy improve COVID-19 outcomes in patients with hematologic cancers?

Targeting lung inflammation with cell membrane-based dexamethasone nanodelivery platform

Targeting lung inflammation with cell membrane-based dexamethasone nanodelivery platform

Novel vaccine based on mRNA technology protects against malaria in animal models

Novel vaccine based on mRNA technology protects against malaria in animal models

RIG-1 agonist shows potent antiviral efficacy against SARS-CoV-2 infection

RIG-1 agonist shows potent antiviral efficacy against SARS-CoV-2 infection

Combination of interferon-α and nafamostat inhibits SARS-CoV-2 in vivo

Combination of interferon-α and nafamostat inhibits SARS-CoV-2 in vivo

COVID-19 outbreak in Mauritius dominated by new SARS-CoV-2 variant B.1.1.318

COVID-19 outbreak in Mauritius dominated by new SARS-CoV-2 variant B.1.1.318

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.